REQUEST A DEMO
Total
USD $0.00
Search more companies

Elva Pharma S.R.O. (Czech Republic)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Elva Pharma S.R.O. Profile Updated: November 03, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Elva Pharma S.R.O. is an enterprise in Czech Republic, with the main office in Cernosice. The enterprise currently operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. It was established on November 10, 2015. It currently has a total number of 1 - 5 (2023) employees. The latest financial highlights indicate a net sales revenue increase of 86.48% in 2022. Its’ total assets recorded a growth of 83.95%. The net profit margin of Elva Pharma S.R.O. increased by 6.49% in 2022.

Headquarters
Dr. Janskeho 599
Cernosice; Stredocesky; Postal Code: 25228

Contact Details: Purchase the Elva Pharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Elva Pharma S.R.O. report to view the information.
Outstanding Shares:
Purchase the Elva Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Elva Pharma S.R.O. report to view the information.
Incorporation Date:
November 10, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Elva Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
86.48%
Total operating revenue
86.75%
Operating profit (EBIT)
1993.19%
EBITDA
972.28%
Net Profit (Loss) for the Period
813.83%
Total assets
83.95%
Total equity
N/A
Operating Profit Margin (ROS)
8.97%
Net Profit Margin
6.49%
Return on Equity (ROE)
N/A
Quick Ratio
0.12%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?